Proposal of a new scoring scheme for the diagnosis of noninvasive endocervical glandular lesions

American Journal of Surgical Pathology

Volumn 27, Issue 4, 2003, Pages 452-460

  Ioffe, Olga B ^a   Sagae, Satoru ^b   Moritani, Suzuko ^c   Dahmoush, Laila ^a,e   Chen, Tar T ^d   Silverberg, Steven G ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^b SAPPORO MEDICAL UNIVERSITY   (Japan)

^c SHIGA UNIVERSITY OF MEDICAL SCIENCE   (Japan)

^d UNIVERSITY OF MARYLAND GREENEBAUM CANCER CENTER   (United States)

^e UNIVERSITY OF IOWA   (United States)

Author keywords

Diagnostic reproducibility; Endocervical adenocarcinoma in situ; Endocervical glandular dysplasia

Indexed keywords

ADENOCARCINOMA; ARTICLE; CANCER DIAGNOSIS; DYSPLASIA; FEMALE; GYNECOLOGIC CANCER; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; REPRODUCIBILITY; SCORING SYSTEM; UTERINE CERVIX CARCINOMA; UTERINE CERVIX CARCINOMA IN SITU; UTERINE ENDOCERVIX;

ADENOCARCINOMA; FEMALE; HUMANS; OBSERVER VARIATION; UTERINE CERVICAL NEOPLASMS;

EID: 0344405684     PISSN: 01475185     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000478-200304000-00004     Document Type: Article

References (33)

1. Anciaux D, Lawrence WD, Gregoire L. Glandular lesions of the uterine cervix: prognostic implications of human papillomavirus status. Int J Gynecol Pathol 1997;16:103-10.
2. Andersen ES, Arffmann E. Adenocarcinoma in situ of the uterine cervix: a clinico-pathologic study of 36 cases. Gynecol Oncol 1989;35:1-7.
3. Biscotti CV, Hart WR. Apoptotic bodies: a consistent morphologic feature of endocervical adenocarcinoma in situ. Am J Surg Pathol 1998;22:434-9.
4. Boon ME, Baak JP, Kurver PJ, et al. Adenocarcinoma in situ of the cervix: an underdiagnosed lesion. Cancer 1981;48:768-73.
5. Bousfield L, Pacey F, Young Q, et al. Expanded cytologic criteria for the diagnosis of adenocarcinoma in situ of the cervix and related lesions. Acta Cytol 1980;24:283-96.
6. Brown LJ, Wells M. Cervical glandular atypia associated with squamous intraepithelial neoplasia: a premalignant lesion? J Clin Pathol 1986;39:22-8.
7. Casper GR, Ostor AG, Quinn MA. A clinicopathologic study of glandular dysplasia of the cervix. Gynecol Oncol 1997;64:166-70.
8. Elston CW, Ellis IO. Pathological prognostic factors in breast cancer: I. The value of histologic grade in breast cancer: experience from a large study with long-term follow-up. Histopathology 1991;19:403-10.
9. Farnsworth A, Laverty C, Stoler MH. Human papillomavirus messenger RNA expression in adenocarcinoma in situ of the uterine cervix. Int J Gynecol Pathol 1989;8:321-30.
10. Gloor E, Hurlimann J. Cervical intraepithelial glandular neoplasia (adenocarcinoma in situ and glandular dysplasia): a correlative study of 23 cases with histologic grading, histochemical analysis of mucins, and immunohistochemical determination of the affinity for four lectins. Cancer 1986;58:1272-80.
11. Goldstein NS, Ahmad E, Hussain M, et al. Endocervical glandular atypia: does a preneoplastic lesion of adenocarcinoma in situ exist? Am J Clin Pathol 1998;110:200-9.
12. Higgins GD, Phillips GE, Smith LA, et al. High prevalence of human papillomavirus transcripts in all grades of cervical intraepithelial glandular neoplasia. Cancer 1992;70:136-46.
13. Ioffe OB, Papadimitriou JC, Drachenberg CB. Correlation of proliferation indices, apoptosis, and related oncogene expression (bcl-2 and c-erbB-2) and p53 in proliferative, hyperplastic, and malignant endometrium. Hum Pathol 1998;29:1150-9.
14. Jaworski RC. Endocervical glandular dysplasia, adenocarcinoma in situ, and early invasive (microinvasive) adenocarcinoma of the uterine cervix. Semin Diagn Pathol 1990;7:190-204.
15. Jaworski RC, Pacey NF, Greenberg ML, et al. The histologic diagnosis of adenocarcinoma in situ and related lesions of the cervix uteri: adenocarcinoma in situ. Cancer 1988;61:1171-81.
16. Kashimura M, Shinohara M, Oikawa K, et al. An adenocarcinoma in situ of the uterine cervix that developed into invasive adenocarcinoma after 5 years. Gynecol Oncol 1990;36:128-33.
17. Landis JR, Koch GG. The measurement of observer agreement for categorical data. Biometrics 1977;33:159-74.
18. Leary J, Jaworski R, Houghton R. In-situ hybridization using biotinylated DNA probes to human papillomavirus in adenocarcinoma-in-situ and endocervical glandular dysplasia of the uterine cervix. Pathology 1991;23:85-9.
19. Lee KR, Flynn CE. Early invasive adenocarcinoma of the cervix. Cancer 2000;89:1048-55.
20. Lee KR, Sun D, Crum CP. Endocervical intraepithelial glandular atypia (dysplasia): a histopathologic, human papillomavirus, and MIB-1 analysis of 25 cases. Hum Pathol 2000;31:656-64.
21. Linden MD, Torres FX, Kubus J, et al. Clinical application of morphologic and immunocytochemical assessments of cell proliferation. Am J Clin Pathol 1992;97(suppl):4-13.
22. McCluggage G, McBride H, Maxwell P, et al. Immunohistochemical detection of p53 and bcl-2 proteins in neoplastic and nonneoplastic endocervical glandular lesions. Int J Gynecol Pathol 1997;16:22-7.
23. Moritani S, Ioffe OB, Sagae S, et al. Mitotic activity and apoptosis in endocervical glandular lesions. Int J Gynecol Pathol 2002;21:125-33.
24. Nielsen AL. Human papillomavirus type 16/18 in uterine cervical adenocarcinoma in situ and adenocarcinoma: a study by in situ hybridization with biotinylated DNA probes. Cancer 1990;65:2588-93.
25. Qizilbash AH. In-situ and microinvasive adenocarcinoma of the uterine cervix: a clinical, cytologic and histologic study of 14 cases. Am J Clin Pathol 1975;64:155-70.
26. Schwartz SM, Weiss NS. Increased incidence of adenocarcinoma of the cervix in young women in the United States. Am J Epidemiol 1986;124:1045-7.
27. Shimizu Y, Kamoi S, Amada S, et al. Toward the development of a universal grading system for ovarian epithelial carcinoma: testing of a proposed system in a series of 461 patients with uniform treatment and follow-up. Cancer 1998;82:893-901.
28. Shimizu Y, Kamoi S, Amada S, et al. Toward the development of a universal grading system for ovarian epithelial carcinoma: I. Prognostic significance of histopathologic features: problems involved in the architectural grading system. Gynecol Oncol 1998;70:2-12.
29. Staunton MJ, Gaffney EF. Tumor type is a determinant of susceptibility to apoptosis. Am J Clin Pathol 1995;103:300-7.
30. Tase T, Okagaki T, Clark BA, et al. Human papillomavirus DNA in adenocarcinoma in situ, microinvasive adenocarcinoma of the uterine cervix, and coexisting cervical squamous intraepithelial neoplasia. Int J Gynecol Pathol 1989;8:8-17.
31. Tase T, Okagaki T, Clark BA, et al. Human papillomavirus DNA in glandular dysplasia and microglandular hyperplasia: presumed precursors of adenocarcinoma of the uterine cervix. Obstet Gynecol 1989;73:1005-8.
32. Wells M, Brown LJ. Glandular lesions of the uterine cervix: the present state of our knowledge. Histopathology 1986;10:777-92.
33. Zaino RJ. Glandular lesions of the uterine cervix. Mod Pathol 2000;13:261-74.